Academic Editor

Article Metrics

  • Fig. 1.

    View in Article
    Full Image
  • Fig. 2.

    View in Article
    Full Image
  • Fig. 3.

    View in Article
    Full Image
  • Fig. 4.

    View in Article
    Full Image
  • Fig. 5.

    View in Article
    Full Image
  • Fig. 6.

    View in Article
    Full Image
  • Fig. 7.

    View in Article
    Full Image
  • Fig. 8.

    View in Article
    Full Image
  • Fig. 9.

    View in Article
    Full Image
  • Fig. 10.

    View in Article
    Full Image
  • Fig. 11.

    View in Article
    Full Image
  • Fig. 12.

    View in Article
    Full Image
  • Fig. 13.

    View in Article
    Full Image
  • Fig. 14.

    View in Article
    Full Image
  • Information

  • Download

  • Contents

Abstract

Background:

Bronchopulmonary dysplasia (BPD) is a chronic lung disease in premature infants. Neonatal hyperoxia induces a BPD-like phenotype and lung cell senescence in rodents. In our 3-day hyperoxia model, senescent cells were predominantly lung macrophages, with their abundance peaking at postnatal day 7 (pnd7). However, the molecular and functional characteristics of these senescent macrophages remain undefined.

Methods:

We reanalyzed a scRNA-seq dataset (GSE207866) generated from senescent lung cells isolated at pnd7 (SD7) following neonatal hyperoxia. Hierarchical clustering combined with manual annotation was used to compare transcriptional profiles with age-matched air-exposed controls (AirD7) and hyperoxia-exposed mice without senescent-cell enrichment (O2D7). Key molecular findings were validated by immunofluorescence. In vivo, neonatal mice received daily injections of the pyruvate dehydrogenase kinase inhibitor, dichloroacetate (DCA) from pnd4 to pnd6, and a senolytic cocktail consisting of quercetin and dasatinib from pnd4 to pnd14, following 3 days of hyperoxia exposure.

Results:

Macrophages accounted for 65.90% of senescent cells in the SD7 group. Seven macrophage clusters were identified, enriched in M1-like and alveolar macrophage phenotypes. Two major clusters (clusters 0 and 1), together representing nearly half of all senescent macrophages, exhibited strong expression of genes associated with innate immunity, inflammation, and DNA damage responses. These clusters also showed a shift toward glycolysis, the pentose phosphate pathway, and glutamine metabolism, with reduced reliance on β-oxidation. Administration of DCA activated pyruvate dehydrogenase and attenuated hyperoxia-induced macrophage senescence and lung injury. Pathway enrichment analyses revealed enhanced metal-handling pathways, immune and stress signaling (including p38 mitogen-activated kinase, ataxia-telangiectasia mutated, and mechanistic target of rapamycin), apoptosis, and RNA regulatory processes. Conversely, genes involved in reactive oxygen species detoxification, DNA repair, phagocytosis, cytoskeletal organization, and cell adhesion were downregulated. Notably, reducing senescent cells by a senolytic cocktail during the alveolar stage mitigated hyperoxia-induced persistent lung injury.

Conclusion:

Neonatal hyperoxia drives the emergence of a heterogeneous population of senescent macrophages characterized by metabolic reprogramming and dysregulated signaling pathways, which contribute to the development and persistence of lung injury.

1. Introduction

Bronchopulmonary dysplasia (BPD) is a chronic lung disease of prematurity that arises from a combination of factors, including exposure to supplemental oxygen, mechanical ventilation, and other perinatal insults. In the US, approximately 10,000–15,000 premature infants develop BPD each year, with an estimated first-year medical cost approaching $380,000 per infant [1, 2, 3]. Despite advances in neonatal care that have improved survival, the incidence of BPD and the burden of long-term respiratory morbidity remain largely unchanged [4]. This underscores a critical need for new therapeutic approaches that directly target the mechanisms driving lung injury in BPD.

Emerging evidence indicates that cellular senescence may contribute to the pathogenesis of BPD. Airway smooth muscle cells from oxygen-exposed infants exhibit increased markers of senescence compared with those from infants who died shortly after birth without oxygen exposure [5]. Similarly, premature infants requiring mechanical ventilation show a notable reduction in nuclear lamin B1 in distal alveoli, consistent with heightened senescence [6]. Additional studies have reported increased senescence-associated biomarkers, including lipofuscin accumulation, phosphorylated p53, and γ-H2AX, in the lungs of infants with BPD [7]. Experimental models parallel these clinical findings: neonatal rats and mice exposed to hyperoxia exhibit robust induction of lung cell senescence [6, 7]. In our 3-day neonatal hyperoxia model, senescent cells peak at postnatal day 7 (pnd7), with lung macrophages representing the majority of senescent cell populations [6]. Macrophages in the developing lung encompass diverse functional subsets, yet the specific characteristics of senescent macrophages generated following neonatal hyperoxia remain undefined. Characterizing their phenotypes and molecular pathways is essential for understanding how they contribute to lung damage and for identifying strategies to selectively target these cells.

To address this gap, we reanalyzed a single-cell RNA sequencing dataset (GSE207866) of senescent lung cells isolated from hyperoxia-exposed neonatal mice at pnd7 (SD7). The dataset is limited to senescent cell populations and thus does not include a corresponding hyperoxia-exposed, non-senescent cell-enriched group for comparison. Using hierarchical clustering and comparative transcriptomic analyses [8], we characterized the gene expression profiles and pathway enrichment signatures of senescent macrophages and contrasted them with age-matched air controls (AirD7) and non-senescent cells from hyperoxia-exposed mice (O2D7). Portions of these analyses have been deposited in bioRxiv [9]. Mice were injected a pyruvate dehydrogenase (Pdh) kinase (PDK) inhibitor to determine whether activating Pdh decreases hyperoxia-induced macrophage senescence, alveolar and vascular simplification. Finally, we evaluated whether senolytic treatment during the alveolar stages inhibits neonatal hyperoxia-induced persistent lung injury.

2. Materials and Methods
2.1 Hyperoxic Exposure and Treatment

Newborn C57BL/6J mice (<12 h old, both sexes) and their dams were placed in either room air (21% O2) or 95% O2 for 3 days using an A-chamber system (BioSpherix, Redfield, NY, USA). Dams were rotated between hyperoxia and room air every 24 hours to prevent maternal injury. Pups were subsequently maintained in room air until pnd7 or pnd60. Each pup was treated as an independent biological replicate. Lungs from 3–5 mice originating from 2 litters were collected, with 3–4 mice assigned to each experimental group. Group assignment, data collection, and analysis were performed with the investigator blinded. Sex-specific effects were not assessed. This is because there is no sex difference in lung cellular senescence in neonatal mice after the 3-day hyperoxia [6].

For a senolytic cocktail treatment, mice received quercetin and dasatinib (2.5 and 5 mg/kg, i.p.) from pnd4 to pnd14 following neonatal exposure to room air or hyperoxia. These doses were selected based on prior reports demonstrating effective senescent-cell clearance without toxicity [6]. In a separate experiment, a PDK kinase inhibitor sodium dichloroacetate (DCA, 15 and 30 mg/kg, i.p.) was injected daily between pnd4 and pnd6. Animals were anesthetized with ketamine (75 mg/kg, i.p.) and xylazine (10 mg/kg, i.p.), prepared from stock solutions of ketamine (10%, w/v) and xylazine (2%, w/v) and diluted in sterile saline to achieve the appropriate injection volume. Mice were then cervical dislocated following confirmation of deep anesthesia and complete loss of reflexes, with subsequent removal of vital organs.

2.2 Evaluating Lung Morphometry

Lung morphometric analyses were performed on hematoxylin and eosin (H&E)-stained mouse lung sections. Non-lavaged lungs were gently inflated with 1% low-melting point agarose at a constant pressure of 25 cm H2O and subsequently fixed in 4% neutral-buffered paraformaldehyde. After fixation, lung tissues were paraffin-embedded and sectioned at a thickness of 4 µm using a rotary microtome (Leica Biosystems, Deer Park, IL, USA). Radial alveolar count (RAC) was determined by drawing a perpendicular line from the center of a respiratory bronchiole to the distal acinus, defined by the pleural surface or the nearest connective tissue septum, and counting the number of alveolar septa intersected by this line. At least three measurements were obtained per animal to ensure reliable quantification.

2.3 Immunofluorescence

Paraffin-embedded lung sections underwent deparaffinization and heat-induced antigen retrieval prior to immunofluorescence staining. Samples were incubated overnight at 4 ℃ with primary antibodies against Pdh E1 subunit α1 (Pdha1, ab168379, Abcam, Cambridge, MA, USA, 1:100 dilution), NOS2 (PA1-036, ThermoFisher, Waltham, MA, USA, 1:50 dilution), Syk (PA5-96063, ThermoFisher, 1:100 dilution), transferrin receptor (ab84036, Abcam, 1:100 dilution), or CD68 (ab283654, Abcam, 1:100 dilution), co-staining with lamin B1 (MA1-06103, ThermoFisher, 1:100 dilution) and p21 (MA5-31479, ThermoFisher, 1:100 dilution) as senescence biomarkers. After incubation with goat-anti mouse (A-11001, ThermoFisher) or goat-anti-rabbit (A-11012, ThermoFisher) secondary antibodies (1:5000, 1 h, room temperature), sections were mounted in 4,6-diamidino-2-phenylindole (DAPI)-containing hard-set medium (Vector Labs, Newark, CA, USA). To assess microvascular density, von Willebrand factor (vWF) immunostaining was performed in the lung. Images were acquired using a Nikon fluorescence microscope (Melville, NY, USA).

2.4 Pdh Activity Assay

Pdh activity was assessed in protein lysates prepared from snap-frozen lung tissue using a commercially available kit (ab287837; Abcam). Approximately 50 mg of frozen lung tissue was homogenized in 300 µL of ice-cold assay buffer and incubated on ice for 10 min. The homogenate was then centrifuged at 10,000 ×g for 5 min, and the supernatant was collected. Each sample was transferred to a 96-well plate and brought to a final volume of 50 µL per well with assay buffer. For the positive control, 10 µL of the supplied control material was added to the wells and adjusted to 50 µL with the assay buffer. The enzymatic reaction was initiated by adding 50 µL of the reaction mixture to each well, followed by incubation for 30 min at room temperature in the dark. Pdh enzymatic activity was quantified by measuring absorbance at 450 nm using a Cytation 5 imaging microplate reader (BioTek, Winooski, VT, USA).

2.5 Use of Publicly Available scRNA-seq Datasets

Previously published single-cell RNA-seq data (GEO: GSE207866) from senescent lung cells isolated at pnd7 (SD7) were used for analysis [6]. Single-cell datasets from age-matched air-exposed (AirD7) and hyperoxia-exposed (O2D7) mice served as reference controls.

2.6 Reanalysis of Publicly Available scRNA-seq Dataset

Data processing was carried out in Seurat v4.1.1 (Satija Lab, New York, NY, USA) [10]. CellRanger count matrices (10× Genomics) were imported using Read10X() to create individual Seurat objects. Cells expressing fewer than 200 genes, or genes detected in fewer than three cells, were excluded. Additional filtering removed cells with fewer than 700 or more than 8000 detected genes or >5% mitochondrial transcripts. Quality control was performed as previously described [6].

Normalization and scaling were performed with SCTransform using default parameters. Integration of Seurat objects employed canonical correlation analysis with SelectIntegrationFeatures(), PrepSCTIntegration(), FindIntegrationAnchors(), and IntegrateData(). Principal component analysis (first 50 PCs) was used to build a K-nearest neighbor graph (K = 20), followed by Louvain clustering using FindClusters(). Cluster resolution was guided by clustree v0.5.1 [11]. UMAP visualization was generated using the first 50 CCA embeddings. Cell types were assigned based on established marker genes (Table 1).

Table 1. Canonical gene markers used to identify cell types and subpopulations.
Cell type Canonical markers Level Note
Epithelial Epcam 1
Endothelial Pecam1 1
Mesenchymal Col1a1, Col1a2, Acta2, Myl9 1
Immune Ptprc (Cd45) 1 Selected
Neutrophil S100a9, Ifitm2, Fcgr4 2
Mast cell/Basophil Ms4a2, Cpa3 2
T cells Cd4, Cd3e, Cd8a 2
NK cells Klrd1, Nkg7 2
B cells Cd79a, Cd19 2
Dendritic cell Hba-a1, Hba-a2, Clec9a, Lamp3, Zbtb46, Flt3, Sirpa 2 Selected
Monocyte Cd68, Cd14, S100a8, Fcgr3 (Cd16) 2 Selected
Macrophage Cd68, Itgax (Cd11c), Adgre1 (F4/80), Mertk, Marco, Msr1, Mrc1 (Cd206) 2 Selected
General monocyte Ly6c2, Vcan 3
Classical monocyte Cd14, S100a8 3
Interstitial monocyte/non-classical monocyte Fcgr3 (Cd16), Plac8, Cx3cr1, Spn, Itgal 3
General dendritic cell Zbtb46, Flt3 3
Dendritic cell 1 Clec9a, Itgae (Cd103), Irf8 3
CD301b- dendritic cell 2 S100a4, S100a6, Irf4 3
CD301b+ dendritic cell 2 Mgl2, Cd209a, Siglecg 3
Inflammatory dendritic cell 2 Phf11d, Ifit3, Ifi205 3
Migratory dendritic cell Ccl17, Ccl22 3
General macrophage Cd68, Itgax (Cd11c), Adgre1 (F4/80), Mertk, Marco, Msr1, Mrc1 (Cd206) 3 Selected
Alveolar macrophage Gpd1, Siglec1, Siglecf, Marco, Car4, Fabp1, Krt19 3, 4 Selected
Interstitial macrophage Apoe, Ccl12, C1qc, C1qa, Folr2, Lyve1, Adgre1 (F4/80) 3, 4 Selected
Non-classical interstitial macrophage Ctsz, Ctsd, Esd, Mmp12 3, 4 Selected
Recruited macrophage/Monocyte-derived macrophages Fn1, Il1b, Ccr2, Vcan 3, 4 Selected
Proliferating macrophage Cenpf, Mki67, Stmn1, Top2a, Cdk1 3, 4 Selected
M1 macrophage Cd68, Cd80, Cd86, Cd38, Fcgr3, Fpr2, Stat1, Il1a, Cxcl2, Itgax (Cd11c) 3, 4 Selected
M1/M2 macrophage C1qa, C1qc 3, 4 Selected
M2 macrophage Cd163, Arg1, Arg2, Tgfb1, Fn1, Lyve1, Itgam (Cd11b), Tlr1 3, 4 Selected

The same workflow was repeated iteratively to derive subclusters within each major lineage. Immune cells were isolated from the global dataset, and macrophages were distinguished from monocytes and dendritic cells. This approach yielded seven macrophage subsets (518 cells) for downstream analyses. Marker genes for each macrophage subset were identified using the cosg() function [12]. Figures were generated with SCpubr v2.0.0, scplotter v0.1.1, and fmsb v0.7.6 in R v4.4.1 using RStudio v2023.12.0 (RStudio/Posit, Boston, MA, USA).

2.7 Pathway Analysis Using SCPA

Gene sets representing GO biological processes, KEGG pathways, Reactome, PID, BioCarta, and WikiPathways were obtained from the Molecular Signatures Database (v7) (Broad Institute, Cambridge, MA, USA) [13]. Pathway comparisons were carried out using compare_pathways() in SCPA v1.6.2 (Broad Institute, Cambridge, MA, USA) (parameters: min_genes = 15; max_genes = 500) [14]. Macrophage populations from AirD7, O2D7, and SD7 were analyzed. Visualization and post-processing were performed using Seurat v4.4.0 [10] and ggplot2 v3.5.1 (RStudio/Posit Software, Boston, MA, USA). Pathways with |Fold change| >5 and a Benjamini-Hochberg (BH)-adjusted p-value < 0.01 were selected for subsequent visualization.

2.8 Pseudotime Trajectory Analysis

Single-cell trajectory analysis of seven macrophage clusters was performed using Monocle2 (v2.32.0) (Trapnell Lab, University of Washington, Seattle, WA, USA) [15]. Prior to cell ordering, the differentialGeneTest function was applied to identify differentially expressed genes (DEGs) across clusters, and genes with a q value < 0.01 were selected for pseudotime ordering. Cell trajectories were then constructed using the Discriminative Dimensionality Reduction with Trees (DDRTree) algorithm with default parameters to infer transitional relationships among macrophage clusters. Branch Expression Analysis Modeling (BEAM) was performed on pseudotime-ordered data to identify genes associated with branch fate decisions (Benjamini-Hochberg (BH)-adjusted p value < 1 × 10-5). Trajectory visualizations and heatmaps were generated using the plot_cell_trajectory, plot_complex_cell_trajectory, and plot_genes_branched_heatmap functions. Upregulated genes from branch-specific BEAM analyses were subsequently subjected to pathway enrichment analysis using the DAVID database (https://davidbioinformatics.nih.gov/), and pathways with a BH-adjusted p value < 0.05 were selected for downstream visualization.

2.9 Metabolic Pathway Scoring

AUCell (Version 1.26.0) (Bioconductor, Buffalo, NY, USA) [16] was employed to assign metabolic pathways activity scores in the single-cell RNA data. Initially, a ranking of selected pathways genes was built based on the single-cell expression matrix using the AUCell_buildRankings() function with default parameters. Subsequently, the area under the curve (AUC) was calculated using the top 5% of genes in the ranking using the AUCell_calcAUC() function. Cells expressing a higher proportion of genes within the gene set received higher AUC values. The AUC score for each cell was mapped onto violin and box plots for visualization using the ggplot2 v3.5.1. Finally, the Wilcoxon rank-sum test for multiple comparisons was performed using the stat_compare_means function from the ggpubr v0.6.0 (RStudio/Posit Software, Boston, MA, USA). A p-value < 0.05 was considered statistically significant.

2.10 Statistical Analysis

Data are presented as mean ± SEM. Statistical analyses were performed using GraphPad Prism 9 (GraphPad Software, San Diego, CA, USA) with blinding whenever feasible. Group comparisons were made using unpaired Student’s t-tests with Welch’s correction. For multiple comparisons, the statistical significance of the differences was evaluated by using one-way ANOVA followed by Tukey’s post-test to specifically compare indicated groups. A p-value < 0.05 was considered statistically significant.

3. Results
3.1 Macrophages Constitute the Majority of Senescent Cells After Neonatal Hyperoxia

Using canonical marker genes (Table 1), we first assigned all single cells in the AirD7, O2D7, and SD7 datasets to epithelial, endothelial, immune, or mesenchymal lineages (Table 1, level 1). Immune populations corresponded to clusters 5, 6, 12, 14, 16, 18, 19, 21, 25, 26, 30, 32, and 33 (Fig. 1A). Among the 493 SD7 cells, 73.63% were immune cells, with smaller fractions of epithelial (8.11%), endothelial (9.74%), and mesenchymal (8.52%) cells (Table 2). Thus, immune populations constituted the largest senescent pool.

Fig. 1.

Immune cell and coarse macrophage distributions at postnatal day 7 (pnd7). Reanalysis of public lung scRNA-seq datasets (GSE207866) was performed using lung single-cell suspensions without C12FDG sorting from air-exposed (AirD7) and hyperoxia-exposed (O2D7) mice, as well as C12FDG-sorted cells from the hyperoxia group (SD7). (A,B) Dot plots display cell type identification, including Ptprc (CD45)-positive immune clusters (A) and coarse macrophage/monocyte subpopulations (B). Dot size indicates the proportion of cells expressing the gene within a cluster, and color intensity represents expression levels.

Table 2. Cell types and numbers of immune, epithelial, endothelial and mesenchymal cells.
Cluster Total (n) AirD7 (n) O2D7 (n) SD7 (n)
All 4047 2308 1246 493
Immune 1220 (30.15%) 532 (23.05%) 325 (26.08%) 363 (73.63%)
Epithelial 903 (22.31%) 562 (24.35%) 301 (24.16%) 40 (8.11%)
Endothelial 487 (12.03%) 212 (9.19%) 227 (18.22%) 48 (9.74%)
Mesenchymal 1437 (35.51%) 1002 (43.41%) 393 (31.54%) 42 (8.52%)

To further resolve these immune cells, all immune clusters were combined and reclassified using lineage-specific markers (Table 1, level 2). Eight immune cell types, such as B cells, NK cells, T cells, mast cells/basophils, neutrophils, monocytes, dendritic cells, and macrophages, were identified. Monocytes, dendritic cells, and macrophages accounted for 63.3% of immune cells overall (within clusters 0, 1, 3, 4, 6, 7, 11, and 15), and 97.5% of immune cells in the SD7 group (Fig. 1B; Table 3). Clusters 3 and 6 expressed overlapping signatures of macrophages with monocytes or dendritic cells. These clusters were combined with other myeloid clusters and refined using additional markers (Table 1, level 3).

Table 3. Cell types and numbers of immune cells in AirD7, O2D7 and SD7 groups.
Cluster Total (n) AirD7 (n) O2D7 (n) SD7 (n)
All 1220 532 325 363
Macrophage/Monocyte/DC 772 (63.28%) 246 (46.24%) 172 (52.92%) 354 (97.52%)
Neutrophil 29 (2.38%) 14 (2.63%) 14 (4.31%) 1 (0.28%)
Mast/Basophil 15 (1.23%) 7 (1.32%) 6 (1.85%) 2 (0.55%)
T cells 159 (13.03%) 110 (20.68%) 47 (14.46%) 2 (0.55%)
NK cells 52 (4.26%) 34 (6.39%) 18 (5.54%) 0 (0%)
B cells 193 (15.82%) 121 (22.74%) 68 (20.92%) 4 (1.10%)

This analysis produced eleven initial subclusters (Fig. 2A). Clusters 2, 3, 5, 6, 7, 8, 9, and 10 showed clear macrophage identity, while clusters 1 and 4 contained mixed dendritic cell and macrophage markers. Subclustering of clusters 1 and 4 allowed extraction of macrophages, which were integrated with the eight pre-defined macrophage clusters (Fig. 2B). This produced seven final macrophage subsets (clusters 0–6), totaling 518 macrophages: 116 in AirD7, 77 in O2D7, and 325 in SD7 (Tables 4,5). In SD7, macrophages represented 65.90% of all senescent cells, confirming that macrophages are the dominant senescent population after neonatal hyperoxia. We then used these seven clusters of macrophages for further analyses.

Fig. 2.

Identification of macrophage populations. (A,B) Dot plots depict cell type identification of macrophages from the total coarse macrophage population (A) and the selection of macrophages from mixed subpopulations in clusters 1 and 4 (B). Dot size reflects the percentage of cells expressing each gene, and color intensity represents expression level.

Table 4. Numbers and percentages of macrophages among AirD7, O2D7 and SD7 groups.
Group Total Macrophages
AirD7 (n) 2308 116 (5.03%)
O2D7 (n) 1246 77 (6.18%)
SD7 (n) 493 325 (65.90%)
Table 5. Numbers of macrophages in each cluster.
Cluster Total (n) AirD7 (n) O2D7 (n) SD7 (n)
All 518 116 77 325
0 125 25 18 82
1 112 25 9 78
2 83 21 21 41
3 61 12 5 44
4 56 12 12 32
5 44 14 10 20
6 37 7 2 28
3.2 Senescent Macrophages Predominantly Exhibit an M1 Phenotype

Neonatal hyperoxia drives inflammatory injury with a shift toward M1 polarization [17], but its effects on senescent macrophages are unclear. Polarization analysis of the 325 SD7 macrophages using canonical markers (Table 1) showed that clusters 0, 1, 5, and 6 displayed M1 signatures; cluster 4 aligned with M2; and clusters 2 and 3 exhibited mixed M1/M2 characteristics (Fig. 3A–C). Although total macrophage numbers were reduced in O2D7 compared with AirD7, the distribution of M1, M2, and mixed phenotypes remained similar across groups (Table 6). M1 cells were the dominant subtype in all conditions. Lamin b1 loss is a senescence-associated biomarker [18]. Immunostaining showed that NOS2 (M1 marker) was enriched in lamin b1 negative macrophages at pnd7, whereas the M2-associated protein Syk was reduced in the hyperoxic group compared to air control (Fig. 3D). These results suggest that senescent macrophages formed after hyperoxia predominantly adopt an M1-like inflammatory state.

Fig. 3.

Classification of M1, M2, and mixed M1/M2 macrophages. (A) Dot plot shows expression of curated M1, M2, and mixed M1/M2 genes in total macrophages. The size of the dot represents the percentage of cells within a cluster expressing the indicated gene, while the intensity of expression is indicated by the color legend. Colored boxes are used to highlight marker gene sets that define different macrophage phenotypes and to guide interpretation of the dot plot. (B) Cluster assignment of M1, M2, and mixed M1/M2 macrophages. (C) UMAP plot illustrates the spatial distribution of these macrophages, with cells colored by type; ring plots indicate proportions in each group. (D) Dual immunofluorescence staining of lamin b1 with NOS2 or Syk at pnd7 in hyperoxia-exposed lungs. lamin b1/NOS2+ and lamin b1/Syk+ signals were quantified between air and hyperoxia groups. White arrows indicate representative macrophages showing altered NOS2 or SYK expression and reduced lamin b1 signal. Inset depicts a magnified view of the boxed region to highlight the immunofluorescent signal. Scale bar: 50 µm for the main panel, and 10 µm for the inset. N = 3; *p < 0.05.

Table 6. M1 and M2 macrophage distribution.
Group Macrophages (total cells, %) M1 Mixed M1 and M2 M2
AirD7 (n) 116 (2308, 5.0%) 71 (61.2%) 33 (28.4%) 12 (10.3%)
O2D7 (n) 77 (1246, 6.2%) 39 (50.6%) 26 (33.8%) 12 (15.6%)
SD7 (n) 325 (493, 65.9%) 208 (64.0%) 85 (26.2%) 32 (9.85%)
3.3 Alveolar Macrophages are the Most Common Senescent Macrophage Subtype After Hyperoxia

Because lung macrophages occupy both alveolar and interstitial compartments, we next assessed whether senescence preferentially affects specific subsets. Among the 325 SD7 macrophages, marker-based classification identified alveolar, interstitial, recruited/monocyte-derived, proliferative, and non-classical interstitial macrophages (Table 1). Clusters 0, 1, and 3 corresponded to alveolar macrophages, while clusters 2, 4, 5, and 6 mapped to interstitial, recruited/monocytes-derived, proliferative, and non-classical interstitial macrophages, respectively (Fig. 4).

Fig. 4.

Functional- and tissue-specific macrophage subsets. (A) Dot plot shows expression of curated genes for functional and tissue-specific macrophage subsets. The size of the dot represents the percentage of cells within a cluster expressing the indicated gene, while the intensity of expression is indicated by the color legend. Colored boxes are used to highlight marker gene sets that define different macrophage phenotypes and to guide interpretation of the dot plot. (B) Cluster allocation of alveolar macrophages (AlvMac), interstitial macrophages (IMac), non-classical interstitial macrophages (ncIMac), recruited/monocyte-derived macrophages (recMac/Mo-Mac), and proliferative macrophages (pMac). (C) UMAP plot illustrates the distribution of these macrophages, with ring plots showing subtype proportions in each group.

In O2D7 mice, alveolar macrophage proportions were decreased and interstitial macrophages increased relative to AirD7 (Table 7). The proportions of recruited/monocyte-derived macrophages, proliferative macrophages, and non-classical interstitial macrophages were largely comparable between the AirD7 and O2D7 groups, with no substantial differences observed. In contrast, senescent macrophages in SD7 were predominantly alveolar (62.8%), with reduced representation of interstitial and proliferative subsets compared with the AirD7 group (Table 7). These results indicate that neonatal hyperoxia reshapes the macrophage landscape and that alveolar macrophages are the most susceptible to senescence.

Table 7. Tissues compartments of macrophages in AirD7, O2D7 and SD7 groups.
Group Mac AlvMac IMac ncIMac recMac/Mo-Mac pMac
AirD7 (n) 116 62 (53.4%) 21 (18.1%) 7 (6.03%) 12 (10.3%) 14 (12.1%)
O2D7 (n) 77 32 (41.6%) 21 (27.3%) 2 (2.60%) 12 (15.6%) 10 (13.0%)
SD7 (n) 325 204 (62.8%) 41 (12.6%) 28 (8.62%) 32 (9.85%) 20 (6.15%)

AlvMac, alveolar macrophages; IMac, interstitial macrophages; recMac/Mo-Mac, recruited macrophages/monocytes-derived macrophages; pMac, proliferative macrophages; ncIMac, non-classical interstitial macrophages.

3.4 Monocle2 Pseudotime Analysis Reveals Fate-Associated Transcriptional Programs in Senescent Macrophages

To investigate potential transcriptional state transitions among the seven macrophage clusters, we performed Monocle2 pseudotime trajectory analysis using all clusters (Fig. 5A). The inferred trajectory revealed two major branch points, partitioning cells into five distinct transcriptional states. State 1 mainly comprised clusters 0, 1, 3, and 5; State 2 predominantly consisted of cluster 4; States 3 and 4 were primarily composed of cluster 2; and State 5 mainly included clusters 0, 1, and 5 (Fig. 5B). Based on biological relevance and gene expression characteristics, recMac/Mo-Mac (cluster 4) was annotated as the root state for pseudotime ordering [19, 20]. Accordingly, State 2, which predominantly comprised cluster 4 cells, was designated as the putative early transcriptional state in the inferred trajectory (Fig. 5C).

Fig. 5.

Pseudotime analysis identifies divergent fate programs in senescent macrophages. (A–D) Cell ordering along the differentiation trajectory displayed by clusters (A), branch states (B), pseudotime states (C), and experimental groups (D). (E) Trajectory tree structure illustrating the distribution and relative abundance of macrophage clusters across each branch among the AirD7, O2D7, and SD7 groups. S denotes State. (F) Heatmap of all significantly altered genes identified by branched expression analysis modeling (BEAM) in Monocle at branch point 1. C1–C3 are self-defined gene modules, where “C” denotes Cluster. Specifically, C1 represents a group of genes that are gradually upregulated during differentiation from branch point 1 toward State 3; C2 represents a group of genes that are gradually upregulated during differentiation from branch point 1 toward State 4; and C3 represents genes expressed in the initial cells prior to differentiation toward States 3 and 4. (G) Bar plot of curated significantly enriched pathways (adjusted p < 0.05) derived from genes associated with the differentiation from branch 1 towards State 4.

Cells from the AirD7 and O2D7 groups were primarily distributed toward later pseudotime positions, whereas SD7 cells progressing along branch 2 were enriched at early or intermediate pseudotime stages (Fig. 5D). Fig. 5E depicts the branched trajectory, illustrating the distribution of each cluster across distinct States. The cluster 2 (IMac) cells from the AirD7 and O2D7 groups were predominantly distributed in States 3 and 4, whereas cluster 2 cells from the SD7 group remained in State 4 only along branch 1. The right side of branch 2 corresponds to State 5, which was largely occupied by cells from the SD7 group. State 5 was predominantly composed of clusters 0 and 1 (alvMac) and cluster 6 (ncIMac) in the SD7 group, whereas State 1 was primarily occupied by clusters 0, 1, 3, 5, and 6 in the AirD7 and O2D7 groups. In addition, cluster 5 (pMac) in the SD7 group was mainly distributed at early or intermediate stages of differentiation (i.e., State 2). Together, these distinct cellular distributions indicate divergent fate-associated transcriptional programs in senescent macrophages.

No significant differences in differentiation trajectories along branch 1 were observed between the O2D7 and AirD7 groups (Fig. 5D,E). Therefore, we focused on characterizing differentiation-associated and functional disparities in State 4 (IMac) cells in the SD7 group. To identify genes associated with fate bifurcation, BEAM was applied at branch point 1, revealing genes whose expression dynamics were significantly associated with branch-dependent fate decisions of cluster 2 cells. The C2 gene module (Table 8) was progressively upregulated during differentiation from branch point 1 toward State 4 (Fig. 5F), reflecting gene activation during the transition from cluster 4 (recMac/Mo-Mac) to cluster 2 (IMac) in the SD7 group. In contrast, the C2 module was downregulated during differentiation from cluster 4 to cluster 2 in the AirD7 and O2D7 groups, corresponding to the trajectory from branch point 1 toward State 3. Accordingly, genes in the C2 module were imported into the DAVID database for functional enrichment analysis. Representative significantly enriched pathways associated with differentiation toward State 4 were visualized in a bar plot (Fig. 5G). This includes inflammatory and immune-related pathways such as CCR chemokine receptor binding, chemokine-mediated signaling, TNF, NF-κB, IL-17, and Toll-like receptor signaling, as well as cellular responses to TNF, eosinophil chemotaxis, and MAPK signaling. Collectively, these findings indicate that senescent macrophage-derived interstitial macrophages adopt a pro-inflammatory, fate-associated transcriptional program.

Table 8. A list of genes arranged in different branches in BEAM analysis.
C1 (53 genes) C2 (72 genes) C3 (80 genes)
Top2a Got1 Gm32796
H1f5 Id2 Nlrc3
S100a8 Ifi207 S100a11
Gda Hspa5 Tmsb10
Rpl41 Zfand5 Lsp1
Rpl36a Irf1 Mgst1
Alox5ap Rasgef1b Chil3
Rassf3 Mdfic Atp6v0d2
Smpdl3a Ccnl1 Anxa2
Prdx5 Ctsz Ccl6
S100a6 Ctsl Gdf15
Emb Klf6 Gadd45g
Sparc Clec4e Prdx1
Ccr2 Rgs1 Slc7a11
S100a4 Map2k3 Mt2
Cldn18 Cxcr4 Bhlhe41
Fn1 Impact Mt1
Napsa Nlrp3 Creg1
Gm9733 Krt7 Marco
Hbb-bs Acp5 Cd36
Hba-a1 Gas2l3 Mapk6
Hba-a2 Lilrb4a Ralgds
Eln Por Mfsd12
Hbb-bt Cxcl2 Plek
Rps27rt Cd63 Atp6v1g1
Rpl27a Ubb Lmna
Ifitm3 Slc3a2 Gpr137b
Ifi27l2a H3f3b Spp1
Cbr2 Atp6v0c-ps2 Tnfaip2
Ednrb Pnrc1 Lipa
Rps15a-ps6 Nfe2l2 Dst
Anp32a Atf3 Ctsd
Ccnd3 Nfkbia Plin2
Rab27a Slc38a2 Sgk1
Timm10b Tiparp Nceh1
Coro1a Basp1 Il1rn
Samhd1 Retnla Atp6v1b2
Rpl37rt Pdgfb Ndnf
Sftpc Plau Bc1
Lyz1 Cxcl10 Fabp5
Emilin2 Ccl7 Soat1
Slc34a2 Arl4c Kcnq1ot1
F5 Zfp36 Fth1
Alas2 Junb Lgals3
Scgb1a1 Jun Rab8b
Sftpa1 Ccrl2 Mmp12
Plac8 Vegfa Tlr2
Wfdc2 Cxcl1 Gpr137b-ps
Ltb4r1 Ier3 Ftl1
Gpr35 Cd14 Esd
Spli Ctsb Lilr4b
Clic5 Plk2 Fnip2
Col4a4 Fam20c Csf2rb2
Fos Cstb
Dusp1 Gna13
Cd74 Mir22hg
Apoe Sqstm1
Ccl3 Rn7sk
Ninj1 Srxn1
Ccl4 Hmox1
Ccl2 Txnrd1
Egr1 Cebpa
Prg4 Naa50
Mfap4 Malat1
Col1a1 Neat1
Mrc1 Atp6v1a
Rhob Eif1a
Abca1 Ubc
Cd83 Mdm2
Runx1 mt-Rnr2
Xist Dtnbp1
Cebpb Gclc
Skil
Ifrd1
Ankrd12
Atf4
Eea1
Bcl2a1b
Erdr1-1
Spag9
3.5 Upregulated Genes Define Functional Diversity Among Senescent Macrophage Clusters

To identify defining features of each senescent macrophage subset, we used cosg() [12] to extract the top upregulated genes (Table 9). The predominant functional categories for each cluster were as follows: Cluster 0—innate immunity, inflammation, lipid metabolism, pentose phosphate pathway; Cluster 1—inflammatory and DNA repair programs; Cluster 2—lipid-associated macrophage markers; Cluster 3—downregulated immune activity and thermogenic genes; Cluster 4—migration and recruitment signatures; Cluster 5—cell-cycle regulation; Cluster 6—lysosomal pathways (Fig. 6A,B). Clusters 0, 1, and 3 were expanded in SD7 relative to AirD7 and O2D7 (Fig. 6C), indicating that senescent macrophages are enriched for inflammatory, metabolic, and innate immune programs.

Fig. 6.

Characterization of macrophage subclusters. (A) Dot plot displays the top ten genes identified in each subcluster using the Cell-type-specific One-vs-all Statistical Gene identification (COSG) algorithm. The size of the dot represents the proportion of cells within a cluster expressing the indicated gene, while the intensity of expression is indicated by the color legend. (B) Biological processes associated with each subcluster’s marker genes. (C) Radar plot depicts the proportion of each macrophage subcluster across the three groups.

Table 9. Top 50 genes in individual clusters of macrophages.
0 1 2 3 4 5 6
Cdc42ep3 Mcm2 C1qc Gm36027 Adamdec1 Ccnb2 Cracr2a
Il18 Car4 C1qa Megf11 S100a4 Cdca3 Atp6v1e1
Acot1 Cdc42ep2 C1qb Ucp1 Gpr141 Hmmr Cox6a2
Lima1 Dut C3ar1 Zmat3 Gm9733 Cenpm Stra6l
Rpia Per2 Tmem176b Pcyox1l Ccr2 Birc5 1700003F12Rik
Krt19 Bok Fcrls Gm15738 Cd300lg Ube2c Fam181b
Nabp1 C1ra Ms4a7 Vopp1 Napsa Cenpe Clec1b
Cnr2 Dhcr24 Tmem176a Ppp1r16a Ece1 Cdc20 Gpnmb
Ccdc125 Abhd17c Igfbp4 Gm42027 Plac8 Cdkn3 Gm36598
Pag1 Pole Apoe Nlrc3 Adgre4 Lockd Gm34223
Ipmk Krt79 Gas7 Mamdc2 Ldhb Aspm Anpep
Ear1 Mcm5 Pdlim4 Lat Emb Cenpf Cfb
Gstm1 Mcm6 Ckb Nt5e S100a6 Pimreg Gm14321
Plcb1 Hsdl2 Marcksl1 Mmp12 Pilrb2 Cep55 Igf2r
Pla2g4a Topbp1 Sdc4 Mmp19 Palm Racgap1 4632404H12Rik
Rassf5 Serpinb1a Cd86 Gm34945 Krt80 Kif4 Ccdc66
Mpc2 Ndufs5 Stab1 Tctn3 Ltb4r1 Kif15 Ryr1
Pnpla8 Dtymk Cfh Slc6a4 Itga4 Kif20a Ercc2
Me2 Gmpr Tmem37 Sfxn3 Sorl1 Bub1 Ptpn21
Sh2d1b1 Mcm4 Ifitm2 Mertk Plcl1 Kif20b Vwf
Hsd17b4 Eno1b Gas6 Selplg Mcub Knstrn Angptl3
Ear2 Marco Marcks Cd274 Hp Foxm1 N6amt1
Gm31734 Tipin Maf Ccpg1 Treml4 Dlgap5 Ass1
Zfyve26 Chaf1a Ninj1 Ermp1 Nr4a1 Tpx2 Homez
Dgat2 Gk Pla2g7 Mcam Gpr132 Knl1 Zfp953
Prkar2b Flrt3 Mef2c Pip5k1c Hpgd Sgo2a Gm40785
Pygl Fdps Abca9 Pik3r6 Gm32089 Kif2c Gm20658
Rab29 Phgdh Lacc1 Itgax Atp1a3 Ankle1 Igf2bp2
Card11 Hmgn5 Slc11a1 Cdh1 Pilrb1 Nuf2 Lrrc42
Abcg1 Lrp8 Gpr65 Gm20219 Dgkg Ccnb1 Gng11
Atxn1 Ch25h Aoah St3gal2 Adssl1 Prc1 Gm14057
Fam192a Snx7 Lpcat2 Miip Htra3 Ccna2 Zranb3
Arfip1 Rbm14 Slc9a9 P2ry14 Adgre5 Pclaf Epas1
Nucb2 Mcm7 Itga9 Klf16 Gm14548 Plk1 Ift43
Spns1 Fosl1 Smagp Lif Axdnd1 Mki67 Ear6
Atp6v0d2 LOC115490125 Fyb E030024N20Rik Skint3 Kif23 Ccbe1
Serpinb1a Aasdhppt Itsn1 Mgmt Gm2a Iqgap3 Ptgir
Ndufaf5 Vars2 Ms4a6b Cnot6l Tatdn3 Mxd3 Dcun1d3
Glrx2 Lig1 S1pr1 Pros1 Cnn2 Cit Zscan12
Tnfaip2 Cdca7 Ccl2 Pus10 Cd244a Ska1 Nme7
Abcd2 Lig3 Cx3cr1 Coro6 Atp10d Nusap1 AU022252
Mrpl1 Spp1 Serpinb8 Colec12 Kcnn4 Spc25 Slc2a1
C530008M17Rik Uhrf1 Hpgds L1cam Gm20559 Shcbp1 LOC115488151
Myo6 Ccnd2 Mafb Siglecf Lilra6 Cep72 Cd200
Fam129a Mcm3 Blnk Pbxip1 Itgb7 Top2a Rbks
Plscr1 Tma16 Ctla2b Agap1 Stx2 Cdca8 Mllt3
Plin2 Il1rn Pmp22 Gm38927 Arhgap15 Tacc3 2810454H06Rik
Cttnbp2nl Vaultrc5 Zfp36l1 Ppt1 Gpr35 Zwilch Gm29243
Sort1 Krt19 Man1a AY036118 LOC115489965 Ncapd2 Ric8b
Nlrp1b Plpp1 Igf1 Mctp1 Cd52 Ect2 Il7r
3.6 Senescent Macrophages Favor Glycolysis and the Pentose Phosphate Pathway Over Fatty Acid β-oxidation

Because clusters 0 and 2 expressed metabolic signatures, we evaluated metabolic gene expression across groups. Clusters 0 and 1 expressed high levels of metabolic genes, whereas cluster 2 showed comparatively lower expression (Fig. 7A). Relative to AirD7 and O2D7, SD7 macrophages displayed higher glycolysis genes (Slc2a1, Pkm, Pfkfb3, Ldha, Hk2, Gapdh), higher pentose phosphate pathway genes (Tkt, Taldo1, Pgd, G6pdx), and lower β-oxidation genes (Hadh, Eci1/2, Echs1, Acads/Acadsb, Acaa2) (Fig. 7B). Pathway analysis confirmed enrichment of glycolysis, glutamine metabolism, and TCA cycle-related pathways, and suppression of fatty acid β-oxidation (Fig. 7C). Pdha1, a key regulator linking glycolysis to oxidative phosphorylation, was reduced in lamin b1 negative macrophages after hyperoxia compared to the air control (Fig. 7B,D).

Fig. 7.

Metabolic gene expression and pathway enrichment in macrophage subclusters. (A,B) Dot plots show metabolic gene expression in macrophage subclusters (A) and across AirD7, O2D7, and SD7 groups (B). The size of the dot represents the percentage of cells within a cluster expressing the indicated gene, while the intensity of expression is indicated by the color legend. (C) Metabolic pathway enrichment was assessed using the compare_pathways() function in SCPA, with Wilcoxon tests for significance. ****p < 0.0001, while ns indicates no significance. (D) Dual immunofluorescence of Pdha1 and lamin b1 in pnd7 lungs; lamin b1/Pdha1+ intensity was compared between air and hyperoxia groups. White arrows indicate representative macrophages showing reduced Pdha1 and lamin b1 immunoreactivity. Inset depicts a magnified view of the boxed region to highlight the immunofluorescent signal. Scale bar: 100 µm for the main panel, and 10 µm for the inset. N = 3. *p < 0.05.

Because clusters 0, 1, and 3 constituted 62.8% of SD7 macrophages, we assessed metabolic changes specifically within these clusters. In all three clusters, glycolysis and glutamine metabolism were increased, while β-oxidation genes were consistently reduced in the SD7 group compared to the AirD7 and O2D7 groups (Figs. 8,9,10). The TCA genes were unaltered in clusters 1, 2 or 3 among AirD7, O2D7 and SD7 groups (Fig. 10). However, mitochondrial complexes I, II, IV, and V genes were upregulated, whereas the complex III gene Bcs1l was decreased in the SD7 group compared to the AirD7 and O2D7 groups (Fig. 11). Together, these findings suggest that senescent alveolar macrophages undergo a metabolic shift toward glycolysis and glutamine utilization.

Fig. 8.

Metabolic profiles in alveolar macrophage subcluster 0. (A) Dot plot shows metabolic gene expression in subcluster 0 across AirD7, O2D7, and SD7 groups. The size of the dot represents the percentage of cells within a cluster expressing the indicated gene, while the intensity of expression is indicated by the color legend. (B) Pathway enrichment was evaluated using compare_pathways() in SCPA; significance was assessed by Wilcoxon test. ***p < 0.001, ****p < 0.0001, while ns indicates no significance.

Fig. 9.

Metabolic profiles in alveolar macrophage subcluster 1. (A) Dot plot displays metabolic gene expression in subcluster 1 across AirD7, O2D7, and SD7 groups. The size of the dot represents the percentage of cells within a cluster expressing the indicated gene, while the intensity of expression is indicated by the color legend. (B) Pathway enrichment analysis was performed using SCPA; statistical significance is indicated as *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, respectively, while ns indicates no significance.

Fig. 10.

Metabolic profiles in alveolar macrophage subcluster 3. (A) Dot plot shows metabolic gene expression in subcluster 3 among the three groups. The size of the dot represents the percentage of cells within a cluster expressing the indicated gene, while the intensity of expression is indicated by the color legend. (B) Pathway enrichment in subcluster 3 assessed with SCPA. Wilcoxon test was used to evaluate statistical significance among these groups. *p < 0.05, ***p < 0.001, ****p < 0.0001, respectively, while ns indicates no significance.

Fig. 11.

Mitochondrial electron transport chain genes in alveolar macrophages. Dot plots show expression of mitochondrial electron transport chain genes in macrophage subclusters 1, 2, and 3 across AirD7, O2D7, and SD7 groups. Dot size represents the proportion of cells expressing each gene, and color intensity indicates expression level.

3.7 Pathway Enrichment Analyses Reveal Dysregulated Metabolic, Inflammatory, and Repair Pathways in Senescent Macrophages

Using SCPA to compare GO biological processes across groups, we identified pathway alterations characteristic of senescent macrophages. Volcano plots show broad upregulation and downregulation of signal pathways in SD7 relative to AirD7 and O2D7 (Fig. 12A; Tables 10,11,12,13). Upregulated pathways in SD7 group included metal metabolism and homeostasis, amino acid metabolism, interleukin signals, immune effector process, robo receptor signaling, apoptotic signal pathway, heme oxygenase 1 regulation, and RNA process and translation compared to AirD7 (Table 10) and O2D7 (Table 11). Transferrin receptor is a membrane protein which binds to transferrin and mediates cellular iron uptake. This protein is also regulated by intracellular iron levels. Transferrin receptor expression was increased in lamin b1-negative macrophages after neonatal hyperoxia (Fig. 12B), supporting enhanced iron uptake and metabolism in senescent cells.

Fig. 12.

Pathway enrichment in macrophages. Pathway analysis was performed using compare_pathways() in SCPA. (A) Volcano plots show up- and down-regulated pathways in SD7 vs. AirD7 (top) and O2D7 (bottom). (B) Dual immunofluorescence of transferrin receptor (TR) and lamin b1 in pnd7 lungs; and its intensity was compared between air and hyperoxia groups. White arrows indicate representative lamin b1+/TR+ macrophages in lung sections. Inset depicts a magnified view of the boxed region to highlight the immunofluorescent signal. Scale bar: 50 µm for the main panel, and 10 µm for the inset. N = 3. (C) Violin plots show differences in p38 MAPK, ATM, mTOR (increased) and JAK/STAT (decreased) pathways in SD7 vs. AirD7 and O2D7; SCPA used for statistics. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, respectively, while ns indicates no significance.

Table 10. Top 50 upregulated pathways in senescent macrophages (SD7) compared to AirD7 group.
Pathway pval adjpval qval FC
REACTOME_Signaling by robo receptors 5.24 × 10–⁢78 2.79 × 10–⁢74 8.58 1731.38
REACTOME_Translation 1.91 × 10–⁢82 1.02 × 10–⁢78 8.83 1713.45
REACTOME_Neutrophil degranulation 4.35 × 10–⁢94 2.31 × 10–⁢90 9.47 1689.21
REACTOME_Regulation of expression of slits and robos 4.05 × 10–⁢75 2.16 × 10–⁢71 8.41 1675.73
REACTOME_Metabolism of amino acids and derivatives 1.91 × 10–⁢82 1.02 × 10–⁢78 8.83 1672.43
REACTOME_Cellular response to starvation 3.28 × 10–⁢80 1.74 × 10–⁢76 8.70 1649.93
REACTOME_Eukaryotic translation initiation 1.07 × 10–⁢73 5.71 × 10–⁢70 8.32 1586.57
REACTOME_Influenza infection 1.79 × 10–⁢79 9.54 × 10–⁢76 8.66 1578.42
REACTOME_rRNA processing 4.05 × 10–⁢75 2.16 × 10–⁢71 8.41 1571.55
REACTOME_Response of Eif2ak4 Gcn2 to amino acid deficiency 9.74 × 10–⁢79 5.18 × 10–⁢75 8.62 1570.08
REACTOME_Srp dependent cotranslational protein targeting to membrane 4.05 × 10–⁢75 2.16 × 10–⁢71 8.41 1550.43
REACTOME_Nonsense mediated decay nmd 4.05 × 10–⁢75 2.16 × 10–⁢71 8.41 1548.40
GOBP_Cytoplasmic translation 1.48 × 10–⁢76 7.87 × 10–⁢73 8.49 1547.07
REACTOME_Eukaryotic translation elongation 1.48 × 10–⁢76 7.87 × 10–⁢73 8.49 1541.40
REACTOME_Selenoamino acid metabolism 5.24 × 10–⁢78 2.79 × 10–⁢74 8.58 1538.65
KEGG_Ribosome 4.05 × 10–⁢75 2.16 × 10–⁢71 8.41 1506.81
GOBP_Maintenance of location 2.45 × 10–⁢89 1.31 × 10–⁢85 9.21 1285.58
GOBP_Maintenance of location in cell 2.45 × 10–⁢89 1.31 × 10–⁢85 9.21 1200.99
GOBP_Transition metal ion homeostasis 2.45 × 10–⁢89 1.31 × 10–⁢85 9.21 1174.83
GOBP_Cellular transition metal ion homeostasis 2.45 × 10–⁢89 1.31 × 10–⁢85 9.21 1152.31
REACTOME_Iron uptake and transport 2.75 × 10–⁢93 1.46 × 10–⁢89 9.43 1034.45
GOBP_Regulation of binding 1.07 × 10–⁢81 5.70 × 10–⁢78 8.79 905.97
GOBP_Iron ion homeostasis 4.04 × 10–⁢90 2.15 × 10–⁢86 9.26 904.17
GOBP_Cellular iron ion homeostasis 2.75 × 10–⁢93 1.46 × 10–⁢89 9.43 883.85
REACTOME_Trans golgi network vesicle budding 5.23 × 10–⁢87 2.78 × 10–⁢83 9.09 806.38
REACTOME_Golgi associated vesicle biogenesis 5.23 × 10–⁢87 2.78 × 10–⁢83 9.09 779.28
GOBP_Transition metal ion transport 5.95 × 10–⁢84 3.16 × 10–⁢80 8.92 773.62
GOBP_Regulation of protein containing complex assembly 3.39 × 10–⁢83 1.80 × 10–⁢79 8.87 759.23
GOBP_Iron ion transport 1.91 × 10–⁢82 1.02 × 10–⁢78 8.83 759.16
KEGG_Porphyrin and chlorophyll metabolism 4.04 × 10–⁢90 2.15 × 10–⁢86 9.26 758.28
REACTOME_Signaling by interleukins 2.52 × 10–⁢97 1.34 × 10–⁢93 9.64 758.11
GOBP_Ribonucleoprotein complex biogenesis 3.85 × 10–⁢68 2.05 × 10–⁢64 7.98 740.61
REACTOME_Scavenging by class a receptor 1.38 × 10–⁢71 7.34 × 10–⁢68 8.19 731.72
GOBP_Positive regulation of locomotion 2.75 × 10–⁢93 1.46 × 10–⁢89 9.43 731.33
GOBP_Regulation of transmembrane transport 1.90 × 10–⁢65 1.01 × 10–⁢61 7.81 721.68
REACTOME_Activation of the mRNA upon binding of the cap binding complex and Eifs and subsequent binding to 43s 8.69 × 10–⁢67 4.62 × 10–⁢63 7.90 713.49
GOBP_Response to wounding 6.61 × 10–⁢91 3.51 × 10–⁢87 9.30 700.62
REACTOME_Diseases of signal transduction by growth factor receptors and second messengers 3.08 × 10–⁢86 1.63 × 10–⁢82 9.04 694.08
KEGG_Regulation of actin cytoskeleton 1.64 × 10–⁢61 8.72 × 10–⁢58 7.55 684.21
GOBP_Negative regulation of binding 3.28 × 10–⁢80 1.74 × 10–⁢76 8.70 673.40
PID_Myc repress pathway 1.07 × 10–⁢81 5.70 × 10–⁢78 8.79 654.06
GOBP_Fibroblast proliferation 3.39 × 10–⁢83 1.80 × 10–⁢79 8.87 647.74
GOBP_Cell chemotaxis 3.28 × 10–⁢80 1.74 × 10–⁢76 8.70 643.66
GOBP_Negative regulation of fibroblast proliferation 4.05 × 10–⁢75 2.16 × 10–⁢71 8.41 642.44
REACTOME_Platelet activation signaling and aggregation 1.48 × 10–⁢76 7.87 × 10–⁢73 8.49 637.33
GOBP_Wound healing 1.72 × 10–⁢92 9.16 × 10–⁢89 9.38 635.72
GOBP_Regulation of DNA binding transcription factor activity 8.83 × 10–⁢88 4.69 × 10–⁢84 9.13 633.86
REACTOME_Binding and uptake of ligands by scavenger receptors 1.04 × 10–⁢84 5.51 × 10–⁢81 8.96 632.66
REACTOME_Signaling by receptor tyrosine kinases 3.08 × 10–⁢86 1.63 × 10–⁢82 9.04 630.20
GOBP_Ribosome biogenesis 1.90 × 10–⁢65 1.01 × 10–⁢61 7.81 629.82
Table 11. Top 50 upregulated pathways in senescent macrophages (SD7) compared to O2D7 group.
Pathway pval adjpval qval FC
GOBP_Cellular transition metal ion homeostasis 1.86 × 10–⁢34 9.90 × 10–⁢31 5.48 1001.11
GOBP_Transition metal ion homeostasis 1.86 × 10–⁢34 9.90 × 10–⁢31 5.48 998.49
REACTOME_Iron uptake and transport 4.52 × 10–⁢32 2.41 × 10–⁢28 5.26 849.00
GOBP_Cellular iron ion homeostasis 6.21 × 10–⁢37 3.31 × 10–⁢33 5.70 751.98
GOBP_Iron ion homeostasis 1.86 × 10–⁢34 9.90 × 10–⁢31 5.48 749.76
REACTOME_Neutrophil degranulation 1.86 × 10–⁢34 9.90 × 10–⁢31 5.48 724.43
KEGG_Porphyrin and chlorophyll metabolism 4.52 × 10–⁢32 2.41 × 10–⁢28 5.26 665.94
GOBP_Maintenance of location in cell 1.44 × 10–⁢27 7.66 × 10–⁢24 4.81 644.84
GOBP_Transition metal ion transport 1.73 × 10–⁢21 9.25 × 10–⁢18 4.13 632.69
GOBP_Iron ion transport 1.73 × 10–⁢21 9.25 × 10–⁢18 4.13 631.68
REACTOME_Scavenging by class A receptors 2.00 × 10–⁢23 1.07 × 10–⁢19 4.36 627.95
REACTOME_Golgi associated vesicle biogenesis 2.00 × 10–⁢23 1.07 × 10–⁢19 4.36 618.57
REACTOME_Trans golgi network vesicle budding 1.88 × 10–⁢25 1.00 × 10–⁢21 4.58 618.26
GOBP_Maintenance of location 1.86 × 10–⁢34 9.90 × 10–⁢31 5.48 611.57
PID_MYC repress pathway 1.73 × 10–⁢21 9.25 × 10–⁢18 4.13 549.94
GOBP_Negative regulation of fibroblast proliferation 1.73 × 10–⁢21 9.25 × 10–⁢18 4.13 547.25
GOBP_Fibroblast proliferation 7.02 × 10–⁢18 3.74 × 10–⁢14 3.66 545.84
REACTOME_Regulation of expression of slits and robos 4.52 × 10–⁢32 2.41 × 10–⁢28 5.26 539.46
REACTOME_Signaling by robo receptors 8.94 × 10–⁢30 4.76 × 10–⁢26 5.03 535.06
REACTOME_Cellular response to starvation 1.88 × 10–⁢25 1.00 × 10–⁢21 4.58 509.59
REACTOME_Metabolism of amino acids and derivatives 1.73 × 10–⁢21 9.25 × 10–⁢18 4.13 503.75
REACTOME_Response of Eif2ak4 Gcn2 to amino acid deficiency 1.44 × 10–⁢27 7.66 × 10–⁢24 4.81 483.29
REACTOME_Selenoamino acid metabolism 1.73 × 10–⁢21 9.25 × 10–⁢18 4.13 471.87
REACTOME_Eukaryotic translation initiation 1.22 × 10–⁢19 6.52 × 10–⁢16 3.90 471.69
REACTOME_SRP dependent cotranslational protein targeting to membrane 1.22 × 10–⁢19 6.52 × 10–⁢16 3.90 470.94
REACTOME_Translation 2.00 × 10–⁢23 1.07 × 10–⁢19 4.36 468.91
REACTOME_rRNA processing 1.73 × 10–⁢21 9.25 × 10–⁢18 4.13 465.72
REACTOME_Nonsense mediated decay NMD 1.73 × 10–⁢21 9.25 × 10–⁢18 4.13 465.16
REACTOME_Binding and uptake of ligands by scavenger receptors 1.88 × 10–⁢25 1.00 × 10–⁢21 4.58 464.40
KEGG_Ribosome 1.73 × 10–⁢21 9.25 × 10–⁢18 4.13 463.05
REACTOME_Influenza infection 2.00 × 10–⁢23 1.07 × 10–⁢19 4.36 457.23
GOBP_Cytoplasmic translation 2.00 × 10–⁢23 1.07 × 10–⁢19 4.36 451.70
REACTOME_Eukaryotic translation elongation 1.22 × 10–⁢19 6.52 × 10–⁢16 3.90 446.34
GOBP_Response to cadmium ion 1.69 × 10–⁢39 8.99 × 10–⁢36 5.92 344.59
GOBP_Cellular response to cadmium ion 1.69 × 10–⁢39 8.99 × 10–⁢36 5.92 340.25
GOBP_Cellular response to inorganic substance 6.21 × 10–⁢37 3.31 × 10–⁢33 5.70 322.96
GOBP_Response to metal ion 1.69 × 10–⁢39 8.99 × 10–⁢36 5.92 279.12
REACTOME_Signaling by interleukins 6.21 × 10–⁢37 3.31 × 10–⁢33 5.70 258.01
GOBP_Negative regulation of growth 4.52 × 10–⁢32 2.41 × 10–⁢28 5.26 254.10
GOBP_Response to copper ion 4.52 × 10–⁢32 2.41 × 10–⁢28 5.26 252.12
GOBP_Cellular response to copper ion 1.88 × 10–⁢25 1.00 × 10–⁢21 4.58 251.86
GOBP_Response to zinc ion 1.88 × 10–⁢25 1.00 × 10–⁢21 4.58 250.47
GOBP_Zinc ion homeostasis 1.22 × 10–⁢19 6.52 × 10–⁢16 3.90 248.70
GOBP_Regulation of apoptotic signaling pathway 1.69 × 10–⁢39 8.99 × 10–⁢36 5.92 238.68
REACTOME_Regulation of hmox1 expression and activity 1.69 × 10–⁢39 8.99 × 10–⁢36 5.92 233.38
GOBP_Divalent inorganic cation homeostasis 4.52 × 10–⁢32 2.41 × 10–⁢28 5.26 219.77
GOBP_Cellular response to chemical stress 1.69 × 10–⁢39 8.99 × 10–⁢36 5.92 216.66
REACTOME_Protein localization 3.73 × 10–⁢42 1.99 × 10–⁢38 6.14 210.47
GOBP_Response to toxic substance 1.86 × 10–⁢34 9.90 × 10–⁢31 5.48 205.29
GOBP_Immune effector process 3.73 × 10–⁢42 1.99 × 10–⁢38 6.14 204.38
Table 12. Top 50 downregulated pathways in senescent macrophages (SD7) compared to AirD7 group.
Pathway pval adjpval qval FC
GOBP_Synaptic membrane adhesion 1.59 × 10–⁢7 0.000843863 1.75 –5.02
GOBP_Chondroitin sulfate proteoglycan metabolic process 2.47 × 10–⁢12 1.31 × 10–⁢8 2.81 –5.09
GOBP_Positive regulation of Rho protein signal transduction 5.47 × 10–⁢36 2.91 × 10–⁢32 5.62 –5.12
GOBP_Regulation of morphogenesis of an epithelium 6.62 × 10–⁢46 3.52 × 10–⁢42 6.44 –5.12
GOBP_Ventricular septum morphogenesis 1.57 × 10–⁢40 8.37 × 10–⁢37 6.01 –5.22
GOBP_Cardiac atrium morphogenesis 1.46 × 10–⁢15 7.78 × 10–⁢12 3.33 –5.25
GOBP_Embryonic eye morphogenesis 7.54 × 10–⁢25 4.01 × 10–⁢21 4.52 –5.26
BIOCARTA_AMI pathway 5.12 × 10–⁢35 2.72 × 10–⁢31 5.53 –5.30
GOBP_Peptide cross linking 4.73 × 10–⁢41 2.52 × 10–⁢37 6.05 –5.33
GOBP_Embryonic skeletal system development 2.50 × 10–⁢58 1.33 × 10–⁢54 7.34 –5.41
GOBP_Neuron projection arborization 6.50 × 10–⁢20 3.46 × 10–⁢16 3.93 –5.42
GOBP_Response to ultraviolet b radiation 7.84 × 10–⁢18 4.17 × 10–⁢14 3.66 –5.42
GOBP_Insulin like growth factor receptor signaling pathway 7.84 × 10–⁢18 4.17 × 10–⁢14 3.66 –5.45
GOBP_Axis elongation 2.44 × 10–⁢14 1.30 × 10–⁢10 3.14 –5.55
REACTOME_Runx2 regulates osteoblast differentiation 1.31 × 10–⁢28 6.96 × 10–⁢25 4.92 –5.58
GOBP_Heart valve development 7.22 × 10–⁢61 3.84 × 10–⁢57 7.51 –5.60
GOBP_Regulation of vasculogenesis 7.10 × 10–⁢16 3.77 × 10–⁢12 3.38 –5.75
GOBP_Positive regulation of cartilage development 5.12 × 10–⁢35 2.72 × 10–⁢31 5.53 –5.77
GOBP_Negative regulation of vascular permeability 1.64 × 10–⁢18 8.71 × 10–⁢15 3.75 –5.81
REACTOME_Chondroitin sulfate dermatan sulfate metabolism 4.73 × 10–⁢41 2.52 × 10–⁢37 6.05 –5.82
GOBP_Response to retinoic acid 1.27 × 10–⁢54 6.76 × 10–⁢51 7.08 –5.92
GOBP_Kidney morphogenesis 2.05 × 10–⁢53 1.09 × 10–⁢49 7.00 –5.99
GOBP_Protein heterooligomerization 3.60 × 10–⁢18 1.91 × 10–⁢14 3.70 –6.00
GOBP_Response to hyperoxia 5.67 × 10–⁢37 3.01 × 10–⁢33 5.70 –6.01
GOBP_Cardiac chamber morphogenesis 8.69 × 10–⁢67 4.62 × 10–⁢63 7.90 –6.19
GOBP_Tooth mineralization 5.12 × 10–⁢35 2.72 × 10–⁢31 5.53 –6.36
PID_Lymph angiogenesis pathway 5.19 × 10–⁢40 2.76 × 10–⁢36 5.96 –6.56
GOBP_Cell aggregation 9.98 × 10–⁢7 0.005303593 1.51 –6.59
GOBP_Neuromuscular junction development 7.09 × 10–⁢50 3.77 × 10–⁢46 6.74 –6.61
REACTOME_Hs gag biosynthesis 7.10 × 10–⁢16 3.77 × 10–⁢12 3.38 –6.75
BIOCARTA_Intrinsic pathway 1.64 × 10–⁢18 8.71 × 10–⁢15 3.75 –7.38
REACTOME_Integrin cell surface interactions 3.38 × 10–⁢70 1.80 × 10–⁢66 8.11 –7.39
GOBP_Outflow tract septum morphogenesis 2.87 × 10–⁢23 1.53 × 10–⁢19 4.34 –7.48
GOBP_Appendage morphogenesis 1.27 × 10–⁢54 6.76 × 10–⁢51 7.08 –7.51
GOBP_Retina vasculature development in camera type eye 3.32 × 10–⁢19 1.76 × 10–⁢15 3.84 –7.61
GOBP_Hydrogen peroxide catabolic process 1.72 × 10–⁢92 9.16 × 10–⁢89 9.38 –7.97
GOBP_Smooth muscle tissue development 1.01 × 10–⁢48 5.35 × 10–⁢45 6.65 –8.10
GOBP_Neuron projection extension involved in neuron projection guidance 5.12 × 10–⁢35 2.72 × 10–⁢31 5.53 –8.28
GOBP_Semi lunar valve development 2.95 × 10–⁢44 1.57 × 10–⁢40 6.31 –8.38
GOBP_Mesonephric tubule morphogenesis 2.37 × 10–⁢45 1.26 × 10–⁢41 6.40 –8.39
REACTOME_Heparan sulfate heparin hs gag metabolism 5.67 × 10–⁢37 3.01 × 10–⁢33 5.70 –8.43
GOBP_Glomerular mesangium development 2.47 × 10–⁢12 1.31 × 10–⁢8 2.81 –8.64
GOBP_Mesenchyme morphogenesis 1.38 × 10–⁢47 7.34 × 10–⁢44 6.57 –8.77
GOBP_Morphogenesis of a branching structure 5.24 × 10–⁢78 2.79 × 10–⁢74 8.58 –8.93
GOBP_Cartilage development involved in endochondral bone morphogenesis 1.01 × 10–⁢48 5.35 × 10–⁢45 6.65 –9.23
GOBP_Regulation of neuron migration 5.67 × 10–⁢37 3.01 × 10–⁢33 5.70 –9.49
GOBP_Mesonephros development 7.22 × 10–⁢61 3.84 × 10–⁢57 7.51 –9.81
REACTOME_A tetrasaccharide linker sequence is required for gag synthesis 4.83 × 10–⁢14 2.57 × 10–⁢10 3.10 –10.05
REACTOME_Defective B4galt7 causes eds progeroid type 8.62 × 10–⁢12 4.58 × 10–⁢8 2.71 –10.10
GOBP_Nephron morphogenesis 4.73 × 10–⁢41 2.52 × 10–⁢37 6.05 –10.18
Table 13. Top 50 downregulated pathways in senescent macrophages (SD7) compared to O2D7 group.
Pathway pval adjpval qval FC
GOBP_Gas transport 1.69 × 10–⁢39 8.99 × 10–⁢36 5.92 –167.68
GOBP_Regulation of supramolecular fiber organization 7.02 × 10–⁢18 3.74 × 10–⁢14 3.66 –134.42
GOBP_Actin filament organization 7.02 × 10–⁢18 3.74 × 10–⁢14 3.66 –133.83
GOBP_Regulation of cytoskeleton organization 1.22 × 10–⁢19 6.52 × 10–⁢16 3.90 –127.75
REACTOME_Rho gtpase cycle 1.44 × 10–⁢27 7.66 × 10–⁢24 4.81 –122.41
REACTOME_L1cam interactions 1.25 × 10–⁢14 6.65 × 10–⁢11 3.19 –114.44
GOBP_Regulation of actin filament-based process 7.02 × 10–⁢18 3.74 × 10–⁢14 3.66 –114.32
GOBP_Synapse organization 2.00 × 10–⁢23 1.07 × 10–⁢19 4.36 –111.60
GOBP_Morphogenesis of an epithelium 2.00 × 10–⁢23 1.07 × 10–⁢19 4.36 –107.78
GOBP_Regulation of actin filament organization 1.25 × 10–⁢14 6.65 × 10–⁢11 3.19 –103.13
GOBP_Cell substrate adhesion 1.44 × 10–⁢27 7.66 × 10–⁢24 4.81 –103.04
REACTOME_Recycling pathway of L1 3.86 × 10–⁢13 2.06 × 10–⁢9 2.95 –101.44
GOBP_Hydrogen peroxide catabolic process 1.88 × 10–⁢25 1.00 × 10–⁢21 4.58 –100.48
GOBP_Hydrogen peroxide metabolic process 4.52 × 10–⁢32 2.41 × 10–⁢28 5.26 –99.66
KEGG_Regulation of actin cytoskeleton 9.76 × 10–⁢12 5.20 × 10–⁢8 2.70 –98.75
REACTOME_Gap junction trafficking and regulation 3.28 × 10–⁢16 1.75 × 10–⁢12 3.43 –96.25
GOBP_DNA repair 2.01 × 10–⁢10 1.07 × 10–⁢6 2.44 –93.55
GOBP_Platelet activation 1.22 × 10–⁢19 6.52 × 10–⁢16 3.90 –93.25
REACTOME_Rho gtpases activate formins 1.73 × 10–⁢21 9.25 × 10–⁢18 4.13 –92.79
GOBP_Platelet aggregation 1.22 × 10–⁢19 6.52 × 10–⁢16 3.90 –91.35
REACTOME_Parasite infection 3.38 × 10–⁢9 1.80 × 10–⁢5 2.18 –90.76
KEGG_Focal adhesion 3.28 × 10–⁢16 1.75 × 10–⁢12 3.43 –89.77
REACTOME_Sensory perception 3.86 × 10–⁢13 2.06 × 10–⁢9 2.95 –89.46
REACTOME_Translocation of Slc2a4 Glut4 to the plasma membrane 7.02 × 10–⁢18 3.74 × 10–⁢14 3.66 –88.34
GOBP_Homotypic cell cell adhesion 1.22 × 10–⁢19 6.52 × 10–⁢16 3.90 –88.11
REACTOME_Rho gtpases activate wasps and waves 2.01 × 10–⁢10 1.07 × 10–⁢6 2.44 –87.54
REACTOME_Rho gtpase effectors 1.88 × 10–⁢25 1.00 × 10–⁢21 4.58 –87.45
GOBP_Regulation of body fluid levels 1.22 × 10–⁢19 6.52 × 10–⁢16 3.90 –87.43
GOBP_Actin filament bundle organization 1.44 × 10–⁢27 7.66 × 10–⁢24 4.81 –87.37
KEGG_Pathogenic escherichia coli infection 1.25 × 10–⁢14 6.65 × 10–⁢11 3.19 –86.44
REACTOME_Factors involved in megakaryocyte development and platelet production 1.25 × 10–⁢14 6.65 × 10–⁢11 3.19 –86.21
GOBP_Response to calcium ion 8.94 × 10–⁢30 4.76 × 10–⁢26 5.03 –84.99
REACTOME_Fcgamma receptor fcgr dependent phagocytosis 1.25 × 10–⁢14 6.65 × 10–⁢11 3.19 –84.86
KEGG_Leukocyte transendothelial migration 3.28 × 10–⁢16 1.75 × 10–⁢12 3.43 –83.13
KEGG_Adherens junction 7.02 × 10–⁢18 3.74 × 10–⁢14 3.66 –81.80
GOBP_DNA recombination 5.19 × 10–⁢7 0.002767894 1.60 –81.45
GOBP_Postsynapse organization 3.28 × 10–⁢16 1.75 × 10–⁢12 3.43 –81.45
GOBP_Morphogenesis of a polarized epithelium 1.25 × 10–⁢14 6.65 × 10–⁢11 3.19 –81.44
REACTOME_Ephb mediated forward signaling 3.86 × 10–⁢13 2.06 × 10–⁢9 2.95 –81.33
GOBP_Synaptic vesicle recycling 2.01 × 10–⁢10 1.07 × 10–⁢6 2.44 –81.04
GOBP_Hhemostasis 1.73 × 10–⁢21 9.25 × 10–⁢18 4.13 –80.95
GOBP_Presynaptic endocytosis 9.76 × 10–⁢12 5.20 × 10–⁢8 2.70 –80.86
GOBP_Reactive oxygen species metabolic process 8.94 × 10–⁢30 4.76 × 10–⁢26 5.03 –80.06
REACTOME_Rho gtpases activate iqgaps 2.00 × 10–⁢23 1.07 × 10–⁢19 4.36 –79.86
REACTOME_Eph Ephrin signaling 7.02 × 10–⁢18 3.74 × 10–⁢14 3.66 –79.78
REACTOME_Cell extracellular matrix interactions 2.01 × 10–⁢10 1.07 × 10–⁢6 2.44 –79.63
REACTOME_Cell junction organization 9.76 × 10–⁢12 5.20 × 10–⁢8 2.70 –79.15
REACTOME_Sensory processing of sound 3.86 × 10–⁢13 2.06 × 10–⁢9 2.95 –78.91
REACTOME_Eph Ephrin mediated repulsion of cells 3.86 × 10–⁢13 2.06 × 10–⁢9 2.95 –77.65
GOBP_Vesicle mediated transport in synapse 9.76 × 10–⁢12 5.20 × 10–⁢8 2.70 –76.72

Upregulated pathways in SD7 group included lung morphogenesis, ROS/H2O2 detoxification, and Rho GTPase signals were downregulated compared with both AirD7 and O2D7 groups (Tables 12,13). Pathways including morphogenesis, development, branching, vasculogenesis, response to retinoic acid, insulin-like growth factor, and Runx2 were downregulated in the SD7 group compared with the AirD7 group (Table 12). Compared to O2D7 group, filament, cytoskeleton and cell junction organization, adhesion, phagocytosis, Eph/ephrin signaling, and DNA repair pathway were also downregulated in SD7 group (Table 13).

In addition, p38 mitogen-activated kinase (p38 MAPK), ataxia-telangiectasia mutated (ATM), and mechanistic target of rapamycin (mTOR) pathways were strongly enriched in SD7, whereas JAK/STAT signaling was reduced (Fig. 12C). Because p38 MAPK, ATM, and mTOR are central regulators of the SASP [21, 22], these findings suggest that senescent macrophages activate pathways that promote SASP production.

3.8 Activating Pdh Decreases Hyperoxia-Induced Macrophage Senescence and Lung Injury

PDK phosphorylates the α subunit of E1, e.g., Ser293, leading to Pdh inactivation. To determine whether activating Pdh represses hyperoxia-induced macrophage senescence and lung injury, mice received a prototypical PDK inhibitor DCA (15 and 30 mg/kg, i.p.) daily between pnd4 and pnd6 after hyperoxia. As shown in Fig. 13A, injection of DCA increased lung Pdh activity in mice exposed to hyperoxia at pnd7. The numbers of lamin b1/CD68+ cells and p21+/CD68+ were increased by hyperoxia at pnd7, and this was decreased by DCA injection at a dose of 30 mg/kg (Fig. 13B,C). At pnd14, injection of DCA significantly decreased mean linear intercept (Lm) and increased RAC in hyperoxia-exposed mice (Fig. 13D). Furthermore, neonatal hyperoxia-induced reduction of vWF-positive vessels was attenuated by the treatment at pnd14 (Fig. 13E). Altogether, activating Pdh decreases neonatal hyperoxia-induced macrophage senescence and lung injury. The animal experiments presented in Fig. 13 were approved under Protocol 2024-003, while all remaining animal work described in this study was conducted under Protocol 21-08-0003.

Fig. 13.

Activating Pdh decreases neonatal hyperoxia-induced macrophage senescence and lung injury. C57BL/6J mice (<12 h old) were exposed to air or hyperoxia for 3 days and allowed to recover in room air until pnd7 (A–C) or pnd14 (D,E). DCA (15 and 30 mg/kg, i.p.) was injected daily between pnd4 and pnd6. (A) Lung Pdh activity was measured. (B) Dual immunofluorescence of p21 and CD68 was performed in mice injected with a dose of DCA at 30 mg/kg. White arrows indicate representative CD68+ macrophages showing p21 induction. Inset depicts a magnified view of the boxed region to highlight the immunofluorescent signal. Scale bar: 20 µm for the main panel, and 10 µm for the inset. (C) Dual immunofluorescence of lamin b1 and CD68 was performed in mice injected with a dose of DCA at 30 mg/kg. White arrows indicate representative CD68+ macrophages showing altered lamin b1 expression. Inset depicts a magnified view of the boxed region to highlight the immunofluorescent signal. Scale bar: 20 µm for the main panel, and 10 µm for the inset. At pnd14, lung Lm and RAC via H&E staining (D) and vessel numbers via CD31 immunostaining (E) were evaluated. Scale bar: 50 µm. N = 4–6. **p < 0.01, *⁣**p < 0.001 vs. Veh/Air; p < 0.05, ††p < 0.01, †⁣††p < 0.001 vs. Veh/O2.

3.9 Senolytic Treatment Reduces Neonatal Hyperoxia-Induced Persistent Lung Injury

We previously demonstrated that dasatinib plus quercetin decreases early senescence in hyperoxia-exposed neonatal lungs [6]. To test whether this treatment also mitigates persistent injury, mice received the senolytic cocktail quercetin/dasatinib (2.5 and 5 mg/kg, i.p.) on pnd4 and pnd14 after neonatal hyperoxia. The numbers of lamin b1/CD68+ cells and p21+/CD68+ were increased by hyperoxia at pnd7, and this was decreased by injection of quercetin/dasatinib (5 mg/kg) (Fig. 14A,B). At pnd60, hyperoxia increased Lm and decreased RAC, consistent with impaired alveolarization, but both changes were significantly improved by senolytic treatment in a dose-dependent manner (Fig. 14C). Neonatal hyperoxia-induced vascular simplification, measured by reduced vWF-positive vessels, was also attenuated by the treatment (Fig. 14D). These findings indicate that reducing senescent lung cells ameliorates long-term structural lung injury after neonatal hyperoxia.

Fig. 14.

Senolytic cocktail mitigates hyperoxia-induced macrophage senescence and persistent lung injury. C57BL/6J mice (<12 h old) were exposed to air or hyperoxia (>95% O2) for 3 days, followed by air recovery until pnd7 (A,B) or pnd60 (C,D). Quercetin (Que, 2.5 and 5 mg/kg) and dasatinib (Das, 2.5 and 5 mg/kg) were administered intraperitoneally every other day from pnd4 to pnd14. (A,B) Dual immunofluorescence of lamin b1 and CD68 (A) and p21 and CD68 (B) was performed in mice injected with a dose of Que/Das at 5 mg/kg. White arrows indicate representative CD68+ macrophages exhibiting altered lamin b1 expression in lung sections. Scale bar: 20 µm. (C,D) Lung alveolar size (Lm) and RAC were assessed by H&E staining, and microvessel (<100 µm) counts were determined by vWF immunofluorescence. N = 4–5. *⁣**p < 0.001 vs. corresponding Air. p < 0.05, ††p < 0.01, †⁣††p < 0.001 vs. corresponding Veh/O2.

4. Discussion

In this study, we analyzed senescent lung cells collected at pnd7 from neonatal mice exposed to hyperoxia and identified macrophages as the predominant senescent population. Seven macrophage clusters were resolved, with clusters 0, 1, and 3 comprising nearly two-thirds of all senescent macrophages. These clusters were enriched for alveolar and M1-like phenotypes, indicating that senescent macrophages are highly heterogeneous and occupy distinct niches in the developing lung. The predominance of M1-associated signatures suggests that senescent proinflammatory macrophages may amplify hyperoxia-induced lung injury through secretion of SASP mediators [17].

Although macrophages represented the majority of senescent cells, we also detected senescent epithelial, endothelial, and mesenchymal cells, consistent with earlier findings in a rat hyperoxia model [7]. In this dataset, 65.9% of senescent cells were macrophages, a lower proportion than our earlier estimate of 92.1% [6]. This discrepancy likely reflects methodological differences. Our previous analysis relied on automated reference mapping [6], whereas the current study applied hierarchical clustering followed by manual curation to refine macrophage subtype assignments [8]. This approach reduces misclassification and yields more stringent identification of macrophage subpopulations.

Resident alveolar macrophages are diminished following neonatal hyperoxia [23]. Our data similarly show reduced numbers and proportions of these cells in the O2D7 group compared with air controls. Because resident alveolar macrophages support vascular development and aid in the retention of endothelial progenitor cells partly through CXCL12 and other trophic factors, their loss may impair reparative processes and contribute to lung injury [23, 24, 25]. Interestingly, the present study reveals that alveolar macrophages form the largest pool of senescent cells following hyperoxia, raising the possibility that their transition into senescence may disrupt normal homeostatic functions and hinder endothelial maintenance.

Although senescence is commonly regarded as a terminal state, senescent cells can reenter the cell cycle when the pathways enforcing arrest are discontinued [26, 27, 28]. Such cells do not revert to their pre-senescent identity but instead adopt a distinct “post-senescent” phenotype [29, 30]. We identified a cluster of macrophages (cluster 5) expressing proliferative markers, including Cenpf, Mki67, Stmn1, Top2a, and Cdk1, suggesting the presence of a subset with proliferative potential. As expected, these potentially proliferative macrophages were less abundant in the SD7 group than in controls. This cluster of cells were mainly distributed at early or intermediate stages of differentiation based on the pseudotime analysis. Whether senescent macrophages can proliferate after hyperoxic injury in vivo remains unclear and warrants investigation using lineage-tracing and histological approaches.

Metabolic reprogramming is a hallmark of senescence, with increased reliance on glycolysis and the pentose phosphate pathway to support SASP production [31, 32, 33]. Our analysis indicates that senescent macrophages favor these pathways over fatty acid β-oxidation. Pdh is a multi-enzyme complex that converts pyruvate into acetyl-CoA through pyruvate decarboxylation, and its E1 subunit performs the first and rate-limiting step of this reaction. Pdha1 is strongly expressed in neonatal alveolar macrophages [34]. The reduced expression of Pdha1 in senescent macrophages suggests suppressed glucose oxidation in the TCA cycle. These cells may instead rely on glutamine metabolism as an anaplerotic source to sustain their enlarged size and secretory activity. Integrating Seahorse analysis of glycolysis and oxidative phosphorylation with single-cell metabolomics in sorted populations is critical to validate transcriptomic predictions and identify the substrates supporting senescent macrophages during hyperoxic injury.

Pdh influences both replicative and oncogene-induced senescence [35, 36]. This is supported by our findings demonstrating reduced macrophage senescence following Phd activation by DCA injection. DCA upregulates the cellular NAD+/NADH ratio by increasing NADH oxidation in mitochondrial complex 1 [37]. Notably, the NAD+/NADH ratio and NAD+-dependent SIRT1 levels are reduced in peripheral blood mononuclear cells of premature infants with BPD [38, 39, 40]. Thus, DCA may attenuate hyperoxia-induced macrophage senescence by increasing the NAD+/NADH ratio, enhancing NAD+-dependent SIRT1 activity, or modulating other signaling pathways, such as AMPK and HIF-1α. Macrophage-specific deletion of Pdha1 would provide further evidence for the role of metabolic reprogramming in hyperoxia-induced senescence within this cell population.

Upregulation of electron transport chain genes in senescent macrophages may increase mitochondrial ROS production, and enhanced iron uptake through the transferrin receptor may further augment oxidative stress. Combined with the observed decrease in ROS-detoxifying and DNA-repair pathways, these processes could generate a self-reinforcing cycle of oxidative damage that stabilizes the senescent phenotype [6]. Given that iron overload can drive ferroptosis, it is possible that iron accumulation may mark senescent macrophages for elimination [41, 42]. Examining ferroptosis-related pathways in senescent macrophages may clarify whether this mechanism contributes to their regulation following hyperoxia. Further experiments are warranted to determine whether iron chelation inhibits hyperoxia-induced senescence in macrophages, or whether induction of ferroptosis preferentially eliminates this population.

Key signaling pathways known to govern senescence, including p38 MAPK, ATM, and mTOR, were enriched in senescent macrophages, along with pathways involved in RNA processing and translation, consistent with enhanced SASP gene expression and protein synthesis. Further studies are warranted to determine whether the SASP secretome from senescent macrophages impairs alveolar epithelial wound healing and endothelial tube formation in vitro, as well as alveolarization and vascularization in vivo, and whether these effects can be attenuated by pathway-specific inhibitors. Conversely, pathways associated with phagocytosis were downregulated, in agreement with reports that senescent macrophages exhibit diminished engulfment capacity [43, 44, 45]. Such impairments could further compromise lung repair by reducing clearance of debris, apoptotic cells, and pathogens. This needs further investigation.

This study did not evaluate long-term lung mechanics, including lung compliance and airway resistance, in adult mice following neonatal senolytic clearance of macrophages, which is essential to link alveolar simplification with functional morbidity. Sex-specific responses to senolytic treatment were not assessed and may limit generalizability. Validation of senescent alveolar macrophage accumulation and associated metabolic phenotypes in human BPD lung tissue would facilitate translational relevance. Additionally, the quercetin/dasatinib cocktail may exert off-target toxicity toward non-senescent cells [46]. Future studies should prioritize the development of targeted approaches to selectively eliminate senescent macrophages for BPD therapy in an optimal therapeutic window.

5. Conclusion

Neonatal hyperoxia induces pronounced cellular senescence in the developing lung, with macrophages-particularly alveolar and M1-polarized subsets-constituting the dominant senescent population. These senescent macrophages undergo metabolic reprogramming characterized by increased reliance on glycolysis and the pentose phosphate pathway, accompanied by dysregulation of oxidative stress responses, inflammatory signaling, and tissue repair pathways. Activation of Pdh attenuates hyperoxia-induced macrophage senescence, while selective clearance of this population mitigates the development of chronic lung injury following neonatal hyperoxia. Collectively, these findings identify senescent macrophages as key mediators of persistent lung injury and highlight metabolic and senescence-associated pathways as potential targets for therapeutic intervention of BPD.

Disclosure

The paper is listed as, “Characterization of hyperoxia-induced senescent lung macrophages in neonatal mice” as a preprint on (bioRxiv) at: https://doi.org/10.1101/2025.05.09.652066.

Availability of Data and Materials

All raw data used and analyzed in this study are available from the corresponding author upon reasonable request. Analysis of the scRNA-seq data used publicly available R packages and custom scripts, which are also available from the corresponding author upon reasonable request.

Author Contributions

FL, JW, WL reanalyzed publicly available scRNA-seq datasets. EP and BM performed animal exposure and immunostaining. HY designed the study, conducted experiments, drafted the initial manuscript, and revised the manuscript. PAD assisted with the experimental design and edited the manuscript. All authors contributed to editorial changes in the manuscript. All authors read and approved the final manuscript. All authors have participated sufficiently in the work and agreed to be accountable for all aspects of the work.

Ethics Approval and Consent to Participate

All animal experiments were reviewed and approved by the Institutional Animal Care and Use Committee of Brown University (IACUC: 21-08-0003) and Providence VA Medical Center (IACUC: 2024-003). Animal experiments were performed according to the ARRIVE guidelines.

Acknowledgment

We thank Katy Hegarty and Emerson Kopsack for their technical support. We thank Dr. Xin Li (Dartmouth College) for his discussion on the scRNA-seq analysis of hierarchical clustering of macrophages. The views expressed in this article are those of the authors and do not reflect the position or policy of the Department of Veterans Affairs or the US Federal Government.

Funding

This work was supported in part by the NIH grant R01HL166327, an Institutional Development Award (IDeA) from the NIGMS of NIH under grant #P30GM149398 (HY), and the Warren Alpert Foundation of Brown University (PAD).

Conflict of Interest

The authors declare no conflict of interest. Given his role as the Editorial Board member, Hongwei Yao had no involvement in the peer-review of this article and has no access to information regarding its peer review. Full responsibility for the editorial process for this article was delegated to Esteban C. Gabazza.

References

Publisher’s Note: IMR Press stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.